These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8750895

  • 1. Regulation of neurotensin receptor mRNA expression by the receptor antagonist SR 48692 in the rat midbrain dopaminergic neurons.
    Yamada M, Bolden-Watson C, Watson MA, Cho T, Coleman NJ, Yamada M, Richelson E.
    Brain Res Mol Brain Res; 1995 Nov; 33(2):343-6. PubMed ID: 8750895
    [Abstract] [Full Text] [Related]

  • 2. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.
    Szigethy E, Beaudet A.
    J Comp Neurol; 1989 Jan 01; 279(1):128-37. PubMed ID: 2563267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Morphological substrate for neurotensin-dopamine interactions in the rat midbrain tegmentum.
    Beaudet A, Woulfe J.
    Ann N Y Acad Sci; 1992 Jan 01; 668():173-85. PubMed ID: 1361112
    [No Abstract] [Full Text] [Related]

  • 7. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
    Steinberg R, Brun P, Fournier M, Souilhac J, Rodier D, Mons G, Terranova JP, Le Fur G, Soubrié P.
    Neuroscience; 1994 Apr 01; 59(4):921-9. PubMed ID: 8058127
    [Abstract] [Full Text] [Related]

  • 8. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
    Azzi M, Betancur C, Sillaber I, Spanagel R, Rostène W, Bérod A.
    J Neurochem; 1998 Sep 01; 71(3):1158-67. PubMed ID: 9721741
    [Abstract] [Full Text] [Related]

  • 9. Neurotensin terminals form synapses primarily with neurons lacking detectable tyrosine hydroxylase immunoreactivity in the rat substantia nigra and ventral tegmental area.
    Woulfe J, Beaudet A.
    J Comp Neurol; 1992 Jul 01; 321(1):163-76. PubMed ID: 1351897
    [Abstract] [Full Text] [Related]

  • 10. Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system.
    Steinberg R, Bougault I, Souilhac J, Gully D, Le Fur G, Soubrié P.
    Neurosci Lett; 1994 Jan 17; 166(1):106-8. PubMed ID: 7514773
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of neurotensin receptor mRNA in the dopaminergic cell groups of the rat diencephalon and mesencephalon.
    Nicot A, Rostène W, Bérod A.
    J Neurosci Res; 1995 Apr 01; 40(5):667-74. PubMed ID: 7602617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.
    Azam L, Winzer-Serhan UH, Chen Y, Leslie FM.
    J Comp Neurol; 2002 Mar 12; 444(3):260-74. PubMed ID: 11840479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.